ZA200107256B - 1,3,4-oxadiazole derivatives and process for producing the same. - Google Patents
1,3,4-oxadiazole derivatives and process for producing the same. Download PDFInfo
- Publication number
- ZA200107256B ZA200107256B ZA200107256A ZA200107256A ZA200107256B ZA 200107256 B ZA200107256 B ZA 200107256B ZA 200107256 A ZA200107256 A ZA 200107256A ZA 200107256 A ZA200107256 A ZA 200107256A ZA 200107256 B ZA200107256 B ZA 200107256B
- Authority
- ZA
- South Africa
- Prior art keywords
- group
- formula
- compound represented
- same meanings
- compound
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 25
- 150000005072 1,3,4-oxadiazoles Chemical class 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims description 71
- -1 (2) a C4 Chemical group 0.000 claims description 19
- 125000000217 alkyl group Chemical group 0.000 claims description 19
- 229910052799 carbon Inorganic materials 0.000 claims description 19
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims description 11
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 10
- 125000002947 alkylene group Chemical group 0.000 claims description 8
- 238000010511 deprotection reaction Methods 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- 231100000252 nontoxic Toxicity 0.000 claims description 3
- 230000003000 nontoxic effect Effects 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 claims description 3
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 3
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims 2
- PRVRMXZBCAWXAA-UHFFFAOYSA-N 2-amino-1-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-3-methylbutan-1-one Chemical compound CC(C)C(N)C(=O)C1=NN=C(C(C)(C)C)O1 PRVRMXZBCAWXAA-UHFFFAOYSA-N 0.000 claims 1
- 230000009435 amidation Effects 0.000 claims 1
- 238000007112 amidation reaction Methods 0.000 claims 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 description 14
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 7
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 4
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 238000006859 Swern oxidation reaction Methods 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 3
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- NKLCNNUWBJBICK-UHFFFAOYSA-N dess–martin periodinane Chemical compound C1=CC=C2I(OC(=O)C)(OC(C)=O)(OC(C)=O)OC(=O)C2=C1 NKLCNNUWBJBICK-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 2
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- 125000006432 1-methyl cyclopropyl group Chemical group [H]C([H])([H])C1(*)C([H])([H])C1([H])[H] 0.000 description 1
- MWFMGBPGAXYFAR-UHFFFAOYSA-N 2-hydroxy-2-methylpropanenitrile Chemical compound CC(C)(O)C#N MWFMGBPGAXYFAR-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- SNCZNSNPXMPCGN-UHFFFAOYSA-N butanediamide Chemical compound NC(=O)CCC(N)=O SNCZNSNPXMPCGN-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- IMHRONYAKYWGCC-UHFFFAOYSA-N nitrosomethane Chemical compound CN=O IMHRONYAKYWGCC-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005447 octyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000004866 oxadiazoles Chemical class 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6606599 | 1999-03-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200107256B true ZA200107256B (en) | 2002-12-02 |
Family
ID=13305090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200107256A ZA200107256B (en) | 1999-03-12 | 2001-08-31 | 1,3,4-oxadiazole derivatives and process for producing the same. |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US6534658B1 (de) |
| EP (1) | EP1162199A4 (de) |
| KR (1) | KR20010102569A (de) |
| CN (1) | CN1350525A (de) |
| AU (1) | AU2941200A (de) |
| BR (1) | BR0008936A (de) |
| CA (1) | CA2367418A1 (de) |
| HU (1) | HUP0200476A3 (de) |
| MX (1) | MXPA01009165A (de) |
| NO (1) | NO20014393L (de) |
| NZ (1) | NZ513921A (de) |
| RU (1) | RU2001124908A (de) |
| TR (1) | TR200102680T2 (de) |
| TW (1) | TW482763B (de) |
| WO (1) | WO2000055145A1 (de) |
| ZA (1) | ZA200107256B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2401240A1 (en) * | 2000-02-03 | 2001-08-09 | Toshihide Horiuchi | 1,3,4-oxadiazole derivatives and process for the preparation thereof |
| AU2001277736A1 (en) * | 2000-08-10 | 2002-02-25 | Ono Pharmaceutical Co. Ltd. | 2-(5-amino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidyl)-n-(1-(2-( -t-butyl-1,3,4-oxadiazolyl)carbonyl)-2-(r,s)-methylpropyl) acetamide hydrochloride |
| WO2002020516A1 (fr) * | 2000-09-08 | 2002-03-14 | Ono Pharmaceutical Co., Ltd. | Nouveaux cristaux de dérivé 1,3,4-oxadiazole, procédé de production de ces cristaux, et médicament à base de tels principes actifs |
| HUP0303631A2 (hu) * | 2000-12-26 | 2004-03-01 | Ono Pharmaceutical Co., Ltd. | Pirimidinszármazékok és eljárás előállításukra |
| US7625912B2 (en) * | 2003-12-19 | 2009-12-01 | Merck & Co. Inc | Mitotic kinesin inhibitors |
| KR20090086802A (ko) | 2008-02-11 | 2009-08-14 | 삼성전자주식회사 | 옥사디아졸렌기를 포함하는 디페노퀴논계 화합물을포함하는 전자사진 감광체 및 이를 채용한 전자사진화상형성장치 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5618792A (en) | 1994-11-21 | 1997-04-08 | Cortech, Inc. | Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase |
| US6015791A (en) * | 1994-11-21 | 2000-01-18 | Cortech Inc. | Serine protease inhibitors-cycloheptane derivatives |
| US5591695A (en) * | 1995-02-08 | 1997-01-07 | American Cyanamid Co. | Herbicidal [1,3,4]oxadiazoles and thiadiazoles |
| RU2217436C2 (ru) * | 1996-12-06 | 2003-11-27 | Кортеч, Инк. | Производные оксадиазола, тиадиазола или триазола, являющиеся ингибиторами сериновых протеаз, и содержащие их фармацевтические композиции |
-
2000
- 2000-03-10 KR KR1020017011573A patent/KR20010102569A/ko not_active Application Discontinuation
- 2000-03-10 TR TR2001/02680T patent/TR200102680T2/xx unknown
- 2000-03-10 HU HU0200476A patent/HUP0200476A3/hu unknown
- 2000-03-10 CA CA002367418A patent/CA2367418A1/en not_active Abandoned
- 2000-03-10 MX MXPA01009165A patent/MXPA01009165A/es not_active Application Discontinuation
- 2000-03-10 NZ NZ513921A patent/NZ513921A/xx not_active Application Discontinuation
- 2000-03-10 AU AU29412/00A patent/AU2941200A/en not_active Abandoned
- 2000-03-10 US US09/936,331 patent/US6534658B1/en not_active Expired - Fee Related
- 2000-03-10 TW TW089104322A patent/TW482763B/zh not_active IP Right Cessation
- 2000-03-10 BR BR0008936-2A patent/BR0008936A/pt not_active IP Right Cessation
- 2000-03-10 CN CN00807456A patent/CN1350525A/zh active Pending
- 2000-03-10 EP EP00907995A patent/EP1162199A4/de not_active Withdrawn
- 2000-03-10 WO PCT/JP2000/001464 patent/WO2000055145A1/ja not_active Application Discontinuation
- 2000-03-10 RU RU2001124908/04A patent/RU2001124908A/ru unknown
-
2001
- 2001-08-31 ZA ZA200107256A patent/ZA200107256B/en unknown
- 2001-09-10 NO NO20014393A patent/NO20014393L/no not_active Application Discontinuation
-
2003
- 2003-01-17 US US10/346,136 patent/US20030153758A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BR0008936A (pt) | 2002-04-09 |
| HUP0200476A3 (en) | 2004-03-29 |
| TR200102680T2 (tr) | 2002-07-22 |
| EP1162199A1 (de) | 2001-12-12 |
| HUP0200476A2 (en) | 2002-08-28 |
| NZ513921A (en) | 2001-09-28 |
| AU2941200A (en) | 2000-10-04 |
| US6534658B1 (en) | 2003-03-18 |
| EP1162199A4 (de) | 2002-06-05 |
| CN1350525A (zh) | 2002-05-22 |
| NO20014393D0 (no) | 2001-09-10 |
| NO20014393L (no) | 2001-11-08 |
| CA2367418A1 (en) | 2000-09-21 |
| MXPA01009165A (es) | 2002-08-20 |
| WO2000055145A1 (fr) | 2000-09-21 |
| KR20010102569A (ko) | 2001-11-15 |
| TW482763B (en) | 2002-04-11 |
| US20030153758A1 (en) | 2003-08-14 |
| RU2001124908A (ru) | 2004-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0839798B1 (de) | Zwischenprodukte zur Herstellung von non-peptiden retroviralproteasehemmenden Verbindungen | |
| US5117006A (en) | Dc-88a derivatives useful as antitumor agents | |
| ES2567047T3 (es) | Derivados de pirimidina anti-virales | |
| KR101217036B1 (ko) | Ｈｃｖ ｎｓ－３ 세린 프로테아제 저해제 | |
| ES2569983T3 (es) | Inhibidores de serinproteasa de tipo tripsina y su preparación y uso | |
| AU670649B2 (en) | Piperazinderivate | |
| CZ300127B6 (cs) | Zpusob prípravy meziproduktu inhibujících proteázy retroviru | |
| CZ250594A3 (en) | Antimicrobial oxazolidinones containing substituted diazine groups | |
| CA2130793A1 (en) | Heterocyclic thrombin inhibitors | |
| JPH06510017A (ja) | 芳香族スルホンアミド化合物、阻害剤及びそれを含有する医薬組成物 | |
| ZA200107256B (en) | 1,3,4-oxadiazole derivatives and process for producing the same. | |
| CS3692A3 (en) | Heterocyclic hydroxylamines, process of their preparation, their use andpharmaceutical preparations comprising said compounds | |
| CZ290984B6 (cs) | Deriváty oxazolidinonkarboxylové kyseliny, způsob jejich výroby a pouľití a farmaceutické přípravky na jejich bázi | |
| KR20180005214A (ko) | 질소 머스타드 유도체의 제조 방법 | |
| CA2478283A1 (en) | Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives | |
| JP2003508522A5 (de) | ||
| CA2218816A1 (en) | Low molecular weight bicyclic-urea type thrombin inhibitors | |
| US6417161B1 (en) | Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors | |
| JP2007528363A (ja) | 凝固因子Ｘａ阻害剤として用いるための塩基−置換ベンジルアミン類似体、それらの製法および使用 | |
| US5952328A (en) | Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors | |
| WO1999026925A1 (fr) | Inhibiteurs de tryptase comprenant des composants d'amide heterocycliques | |
| US5610308A (en) | Process for preparing intermediates for thrombin inhibitors | |
| Yonezawa et al. | Total synthesis of bistratamides G and H from various kinds of δala and δabu-containing oligopeptides | |
| KR100565008B1 (ko) | 4-하이드라지노-3-사이클로부텐-1,2-다이온 유도체 및이들의 제조 방법 | |
| EP1135023A1 (de) | Aminobenzisoxazol-verbindungen und sie enthaltende bibliotheken |